References
- 1. Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta. 2009;1791(6):507–3.
- 2. Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet. 2014;59(1):16-23.
- 3. Abate N. Adipocyte maturation arrest: a determinant of systemic insulin resistance to glucose disposal. J Clin Endocrinol Metab. 2012;97(3):760–3.
- 4. Bertrand AT, Chikhaoui K, Ben Yaou R, Bonne G. [Laminopathies: one gene, several diseases]. Biol Aujourdhui. 2011;205(3):147–62.
- 5. Bissonnette B, Luginbuehl I, Marciniak B, Dalens B. Syndromes: rapid recognition and perioperative imlications. New York: McGraw-Hill; 2006.
- 6. Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, et al. Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28(4):365–70.
- 7. Magre J, Delepine M, Van Maldergem L, Robert JJ, Maassen JA, Meiser M, et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes. 2003;52(6):1573–8.
- 8. Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O’Rahilly S, et al. Phenotypic and genetic heterogenecity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 2003;88(10):4840–7.
- 9. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954;14(2):3390-4.
- 10. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome? Acta Pediatr. 1959;48:555-74.
- 11. Van Maldergem L, Magre J, Khallouf TE, Gedde-Dahl T Jr, Delepine M, Trygstad O, et al. Genotype–phenotype relationships in Berardinelli–Seip congenital lipodystrophy. J Med Genet. 2002;39(10):722–33.
- 12. Roth DE, Schikler KN, Callen JP. Annular atrophic connective tissue panniculitis of the ankles. J Am Acad Dermatol. 1989;21(5 Pt 2):1152-6.
- 13. Bennett T, Allford M. Delayed emergence from anesthesia in a child with congenital generalized lipodystrophy (Berardinelli-Seip syndrome). Paediatr Anaesth. 2012;22(3):298-313.
- 14. Pardini VC, Victoria IM, Rocha SM, Andrade DG, Rocha AM, Pieroni FB, et al. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J Clin Endocrinol Metab. 1998;83(2):503–8.
- 15. Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism. 2004;53(4):513-9.
- 16. Gorden P, Gavrilova O. The clinical uses of leptin. Curr Opin Pharmacol. 2003;3(6):655-9.